This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,461.32 and an ultimate completion date of June 18, 2024. It is a firm-fixed-price delivery order contract, without any set-aside designation.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, the company provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits, to support the DLA's mission of providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Generated 8/27/24, 10:26 AM